Faslodex treatment to be launched by Wunderman

Share this article:
Wunderman has been chosen to launch a consumer campaign for AstraZeneca’s breast cancer treatment Faslodex. Wunderman will handle DTP relationship marketing efforts aimed at raising awareness in late-stage breast cancer patients, as well as DTC efforts. A print campaign is slated for summer 2007.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions